Market Insights Health Pharmaceuticals Vaccines

Other Vaccines - Zambia

Zambia

In Zambia, the revenue in the Other Vaccines market is projected to reach US$6.94m by 2024.
It is expected to show an annual growth rate (CAGR 2024-2029) of 11.26%, resulting in a market volume of US$11.83m by 2029.
When compared globally, United States will generate the most revenue in this market, amounting to US$24,730.00m in 2024.
Zambia is experiencing an increased demand for other vaccines due to the government's efforts to expand immunization programs.

Key regions: Australia, Brazil, United Kingdom, Europe, Canada

Market

Region

Region comparison

Currency

Analyst Opinion

The Other Vaccines market in Zambia has been steadily growing in recent years, driven by several factors that have impacted the healthcare industry in the country.

Customer preferences: Zambian customers have shown an increased demand for vaccines that protect against diseases such as polio, hepatitis B, and meningitis. This is due to the high incidence of these diseases in the country, which has led to a greater awareness of the need for vaccination.

Trends in the market: One of the key trends in the Other Vaccines market in Zambia is the growing adoption of new vaccines that have been developed to protect against emerging diseases. For example, there has been a significant increase in the use of vaccines that protect against Ebola, which has been a major health concern in the region in recent years.Another trend in the market is the increasing availability of vaccines in rural areas of Zambia. This has been facilitated by the expansion of healthcare infrastructure in these areas, which has made it easier for people to access vaccines and other healthcare services.

Local special circumstances: One of the unique factors that has impacted the Other Vaccines market in Zambia is the country's high incidence of HIV/AIDS. This has led to a greater demand for vaccines that can protect against diseases that are more likely to affect people with weakened immune systems.

Underlying macroeconomic factors: Zambia's healthcare industry has been impacted by a range of macroeconomic factors, including government policies, funding constraints, and the availability of healthcare infrastructure. Despite these challenges, the Other Vaccines market in Zambia has continued to grow, driven by increasing demand from customers and the development of new vaccines that address emerging health concerns in the country.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.